Roger D. Klein, MD JD is a board-certified molecular pathologist who was formerly Chief Medical Officer of OmniSeq, Inc., a tumor profiling company that was sold to LabCorp. He has served as medical director of molecular oncology and at several academic institutions, most recently Cleveland Clinic. In addition, he has served as a medical, strategic, and regulatory consultant in the biotechnology, clinical laboratory, diagnostics, and medical device industries for Clients have leading pharmaceutical and diagnostic test manufacturers, a major Silicon Valley Law firm, a major Medicare contractor, and the Department of Justice. A leading figure in the field, Dr. Klein has advised the Departments of Health & Human Services, Food and Drug Administration, the Centers for Medicare & Medicaid Services, and the Centers for Disease Control and Prevention, and held leadership roles on and participated in numerous professional society committees at the Association for Molecular Pathology, the College of American Pathologists, the American Society of Clinical Oncology, the Clinical Laboratory Standards Institute, and the American Medical Association. Dr. Klein has over 50 peer-reviewed articles and book chapters and has received numerous professional and community awards. He completed medical school and an internship at Case Western Reserve Medical School, residency and fellowships at Yale Medical School, and a fellowship at Mayo Clinic. He earned his law degree at Yale Law School. He is licensed to practice medicine in New York, Ohio, and Florida, licensed to practice law in the District of Columbia, Ohio and member of the United States Supreme Court Bar.